MedTrace Logo

Surgery or Chemoradiotherapy for Cervical Esophageal Cancer

NCT05327517 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2022-04-14

No results posted yet for this study

Summary

To compare surgery with definitive chemoradiotherapy for patients with resectable cervical esophageal squamous cell carcinoma.

Conditions

  • Cervical Esophageal Cancer

Interventions

PROCEDURE

Esophagectomy

Patients receive esophagectomy or definitive chemoradiotherapy according to patient preference

Sponsors & Collaborators

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    lead OTHER

Principal Investigators

  • Jie He, MD · Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

  • Yin Li, MD · Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-10
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05327517 on ClinicalTrials.gov